Alliance Healthcare UK to enter into a new wholesale agreement with Neon Healthcare: 1 June 2023

We are pleased to announce that, as of 1 June 2023, Alliance Healthcare UK will become one of the chosen wholesalers to supply selected products of Neon Healthcare to all pharmacies, hospitals, and dispensing doctors in the United Kingdom, including Northern Ireland. 

Click below for full product details:

Neon Healthcare RWA Product List

Alliance Healthcare UK Supports Medicines to Ukraine Campaign

The Medicines to Ukraine pharmacy appeal is led by The Healthcare Distribution Association (HDA), Pharmacists' Defence Association (PDA), and National Pharmacy Association (NPA) in the UK, who are urging pharmacy teams to promote the campaign to customers and members of the public to raise funds.

Alliance Healthcare UK has supported the Medicine to Ukraine campaign through its distribution network; via a coordinated, country-wide poster drop to UK pharmacy stores.

Over 15,000 Medicines to Ukraine posters have been delivered to pharmacies across the UK. The posters are already in pharmacy windows across Europe raising awareness of the campaign.

The Medicines to Ukraine campaign is part of a pan-European effort established by Employed Pharmacists in Europe (EPhEU). The campaign procures and sends specialist hospital medicines that are running low or that are no longer available in Ukraine directly to Ukrainian hospitals that are treating the casualties of the war.

Roughly £220,000 has been raised via the appeal in the UK alone and a total of £3 million has been raised across Europe to date.

Martin Sawer, Executive Director of HDA commented: “Our member companies’ distribution networks ensure a comprehensive, resilient and efficient supply system is always there for community pharmacies, hospitals and dispensing doctors. The Association is delighted that an HDA distributor is making use of its own intensive national network to enable this vital campaign.”

Matt Addison, Operations Director at Alliance Healthcare, said: “Each of the 16,500 pharmacies that we supply each day will play an important role in raising awareness of the Medicines to Ukraine campaign. Alliance Healthcare is fortunate to have an operation ready to help our pharmacy customers activate this important appeal and play its part to help those impacted by the war in Ukraine.”

Alliance Healthcare has previously supported on several similar leaflets drops in support of pharmacy, campaigns including the NHS "Stay Well This Winter" campaign.

Class 4 Caution in use- Metronidazole 200 mg/5 ml Oral Suspension

Drugsrus Limited has informed the MHRA that a small number of bottles of Metronidazole 200 mg/5 ml Oral Suspension 100ml are leaking from the cap.

MHRA drug alert date: 23rd May 2023

MHRA drug alert link:  https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-drugsrus-limited-slash-dawa-limited-metronidazole-200-mg-slash-5-ml-oral-suspension-el-23-a-slash-19?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=10f3e44b-274c-4301-ad8e-9eb2779bb944&utm_content=immediately

This is a caution in use only we are not accepting stock returns.

Further Information

For more information, medical or supply enquiries, please contact Drugsrus Limited on 020 8423 3800, or email info@drugsrus.co.uk.

Class 4 Caution in use- Buccolam 10mg

Orifarm UK Ltd has informed the MHRA that the Patient Information Leaflet (PIL) in one batch of Buccolam 10mg Oromucosal solution has missing information regarding having to break the seal on the inner container before use.

MHRA drug alert date: 22nd May 2023

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-orifarm-uk-ltd-buccolam-10mg-oromucosal-solution-el-23-a-slash-18?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=d06c9595-2c98-4c18-90d1-5b738d6dc70d&utm_content=immediately

This is a caution in use only we are not accepting stock returns.

Further Information

For more information, medical or supply enquiries, please contact 01276 698370, or email uk_enquiries@orifarm.com

Class 4 Caution in use- Simulect 10mg & 20mg powder and solvent for Solution for injection or infusion

Novartis Pharmaceuticals has informed the MHRA that the solvent (water for injections in ampoules) co-packed with the impacted batches of Simulect powder for injection, may contain glass fragments approximately 20 – 800 µm in size.

MHRA drug alert date: 16th May 2023

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-novartis-pharmaceuticals-simulect-10mg-and-20mg-powder-and-solvent-for-solution-for-injection-or-infusion-el-23-a-slash-17?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=d08ff9e2-3185-4fca-b71c-1083f3f9bff0&utm_content=immediately

This is a caution in use only we are not accepting stock returns.

Further Information

For more information, medical or supply enquiries, please contact 01276 698370, or email medinfo.uk@novartis.com

class 3 recall- Gemcitabine 1g/26.3ml & 2g/52.6ml Solution For Infusion Vial

Hikma Farmacêutica Portugal S.A has informed the MHRA of a potential issue impacting the batches listed in this notification.

MHRA Drug alert link: https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-hikma-farmaceutica-portugal-s-dot-a-gemcitabine-1g-slash-26-dot-3ml-and-2g-slash-52-dot-6ml-solution-for-infusion-vial-el-23-a-slash-16

For more information or medical information queries, please contact: Portugalcomplaints@hikma.com or Portugaleupharmacovigilance@hikma.com

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Class 1 recall-Emerade 300 & 500 Auto-Injectors

reason: Pharmaswiss Česka republika s.r.o. and distributor Bausch & Lomb UK Limited is recalling all unexpired batches of Emerade 500 micrograms and Emerade 300 micrograms adrenaline auto-injectors (also referred to as pens) from patients. This is due to an issue identified during an ISO 11608 Design Assessment study where some auto-injectors failed to deliver the product or activated prematurely

MHRA drug alert date  9th May 2023

MHRA ref: MDR 020-05/23

Further Information

For stock enquiries, please contact Bausch & Lomb Customer Services:

Tel: 020 8781 2991

Email: Pharma_CS@bausch.com

For medical information enquiries please contact the Medical Information Team:

Email: medinfo.europe@bauschhealth.com

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

company-led recall: Beambridge 33025 leg bag Short Tube

Beambridge Medical Ltd have informed us that some bags in the affected batch are prone to leaking

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit

Alliance Healthcare UK to enter into a new solus wholesale agreement with

EVER Pharma UK Ltd - 2 May 2023

We are pleased to announce that, as of 2 May 2023, Alliance Healthcare UK will become the only wholesaler to supply selected products of EVER Pharma UK to all pharmacies, hospitals, and dispensing doctors in the United Kingdom.

Click here for full product details.

Alliance Healthcare UK Launches Advisory Board

Alliance Healthcare UK is a leading wholesaler of medicines and healthcare products and serves over 17,000 healthcare providers including community pharmacies, GPs, hospitals, and health centres.

The Advisory Board consists of senior experts from the healthcare sector and provides an invaluable source of advice, ensuring Alliance Healthcare UK’s strategic programme is aligned to NHS priorities and delivers real value to UK patients. 

The Advisory Board is chaired by Alliance Healthcare UK’s Non-Executive Adviser, Chris Martin and has four members: Lord O’Shaughnessy, former Department of Health Minister and Director of the No.10 policy unit; Jeannette Howe, former head of Pharmacy at the Department for Health and Social Care; Claire Ward, Chair of Sherwood Forest Hospitals NHS Foundation Trust and former MP for Watford (1997 – 2010) who served as PPS for the Department for Health (2001-2005) and Justice Minister; Fin McCaul, Managing Director of Prestwich Pharmacy and Fellow of the Royal Pharmaceutical Society.

The Advisory Board has met twice this year at Alliance Healthcare UK’s headquarters in Chessington and will meet quarterly in 2023.

Marie Evans, Managing Director of Alliance Healthcare UK, said: “The Advisory Board is an invaluable resource, bringing great knowledge and experience to challenge Alliance Healthcare UK’s strategy as we continue to support community pharmacy and ensure that our service development priorities align to those of the NHS and improve the lives of patients.”

Find out more about our board members by clicking here.